Company Overview
JHS Svendgaard Laboratories Limited (BSE: 532771 | NSE: JHS) filed its Integrated Annual Report for FY 2025-26 and consolidated financial statements, demonstrating significant operational and financial improvements.
Financial Performance
Revenue Growth: The company achieved 10.5% revenue growth to ₹101.69 crores (FY25: ₹91.99 crores), crossing the ₹100 crore milestone for the first time in five years. Total income reached ₹105.14 crores with other income contributing ₹3.45 crores.
Profitability Improvement: Net loss narrowed dramatically to ₹1.92 crores from ₹19.74 crores in FY25, representing a 90% improvement. Loss before tax stood at ₹(2.29) crores compared to ₹(12.50) crores in previous year.
Financial Position: Total assets increased to ₹21,521.66 lakhs with net worth of ₹175.08 crores. Debt rose to ₹148.12 crores primarily due to term loans for capex and cash credit utilization, resulting in debt-equity ratio increasing to 0.08 from 0.01.
Operational Highlights
Product Mix: Toothbrushes contributed 62% of revenue, toothpaste 24%, talcum 11%, and others 3%. Quarterly performance showed strong Q4 sales of ₹33.70 crores.
Expansion Activities: The company made capital advances of ₹4,621.88 lakhs for manufacturing facilities in Himachal Pradesh (₹2,862.58 lakhs) and Jammu & Kashmir project through subsidiary (₹1,328.30 lakhs).
Business Development: Expanded CSD portfolio from 4 to 12 products, participated in international exhibitions (Beautyworld Middle East 2025, PLMA 2025), and received industry recognition at CMPL 2025.
Corporate Actions & Capital Structure
Share Capital: Paid-up equity share capital stood at ₹87.41 crores after conversion of 18,01,801 warrants at ₹27.75 per share. An additional 18,01,801 warrants lapsed due to non-conversion.
ESOP Scheme: Board approved JHS Svendgaard Laboratories Limited Employee Stock Option Scheme, 2025, granting 33.80 lakh ESOPs at exercise price of ₹10 per option with first vesting scheduled for November 13, 2026.
Investments & Guarantees: Company invested ₹112.50 lakhs in JHS Svendgaard Retail Ventures Limited and provided corporate guarantee of ₹500 lakhs to the subsidiary. Mutual fund investments totaled ₹297.36 lakhs.
Audit & Compliance Matters
Auditor Emphasis: Auditors highlighted capital advances of ₹4,190.82 lakhs for expansion projects, which management considers recoverable and adjustable against future plans.
Internal Control Weaknesses: Identified issues in trade receivables/payables monitoring, inventory tracking, tax balance reconciliation, and non-moving stock classification.
Regulatory Compliance: Company confirmed full compliance with SEBI LODR regulations and Companies Act 2013 provisions. No material orders from regulators/courts impacting going concern status.
Corporate Governance
Board Composition: Six directors including 2 Executive, 1 Non-Executive Non-Independent, and 3 Independent Directors. Ten Board meetings held during FY26 with active committee participation.
Key Management: Mr. Nikhil Nanda (Managing Director), Mr. Paramvir Singh (Director & CEO), Mr. Ashish Goel (CFO), and Mrs. Komal Jha (Company Secretary & Compliance Officer).
Outlook & Dividend
Company remains focused on strengthening its position as integrated FMCG manufacturer through innovation, operational excellence, and strategic expansion. No dividend recommended for FY26 due to business requirements and future plans.
22nd Annual General Meeting scheduled for September 26, 2026, to adopt financial statements and address director reappointments.